Semanteon Capital Management LP bought a new stake in shares of Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 19,860 shares of the company's stock, valued at approximately $417,000.
Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Geode Capital Management LLC grew its holdings in shares of Phibro Animal Health by 5.7% during the 3rd quarter. Geode Capital Management LLC now owns 507,469 shares of the company's stock worth $11,430,000 after acquiring an additional 27,201 shares during the period. Charles Schwab Investment Management Inc. grew its stake in Phibro Animal Health by 8.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 290,656 shares of the company's stock worth $6,104,000 after purchasing an additional 22,263 shares during the period. Bank of New York Mellon Corp raised its holdings in Phibro Animal Health by 2.9% in the fourth quarter. Bank of New York Mellon Corp now owns 272,632 shares of the company's stock worth $5,725,000 after purchasing an additional 7,747 shares in the last quarter. Globeflex Capital L P lifted its position in Phibro Animal Health by 0.8% during the fourth quarter. Globeflex Capital L P now owns 206,595 shares of the company's stock valued at $4,338,000 after buying an additional 1,700 shares during the period. Finally, Jacobs Levy Equity Management Inc. boosted its holdings in shares of Phibro Animal Health by 116.6% during the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 192,255 shares of the company's stock valued at $4,330,000 after buying an additional 103,491 shares in the last quarter. Hedge funds and other institutional investors own 99.34% of the company's stock.
Analyst Upgrades and Downgrades
A number of analysts have recently commented on PAHC shares. StockNews.com cut Phibro Animal Health from a "buy" rating to a "hold" rating in a research report on Tuesday. Barclays boosted their target price on Phibro Animal Health from $20.00 to $22.00 and gave the stock an "underweight" rating in a report on Monday, February 10th. Finally, Morgan Stanley raised their price target on Phibro Animal Health from $20.00 to $25.00 and gave the company an "equal weight" rating in a report on Tuesday, December 17th. Two investment analysts have rated the stock with a sell rating and three have given a hold rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $21.00.
Get Our Latest Stock Analysis on PAHC
Phibro Animal Health Stock Up 0.6 %
Shares of PAHC stock traded up $0.13 during mid-day trading on Wednesday, hitting $21.64. The company's stock had a trading volume of 153,015 shares, compared to its average volume of 177,862. The stock has a market cap of $876.48 million, a price-to-earnings ratio of 45.08, a PEG ratio of 0.45 and a beta of 0.58. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.37 and a current ratio of 3.20. Phibro Animal Health Co. has a 52-week low of $12.17 and a 52-week high of $26.55. The business has a 50-day moving average price of $22.74 and a 200 day moving average price of $22.67.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. Research analysts predict that Phibro Animal Health Co. will post 1.95 EPS for the current fiscal year.
Phibro Animal Health Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Wednesday, March 5th will be issued a dividend of $0.12 per share. The ex-dividend date of this dividend is Wednesday, March 5th. This represents a $0.48 annualized dividend and a dividend yield of 2.22%. Phibro Animal Health's payout ratio is 100.00%.
About Phibro Animal Health
(
Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Further Reading
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
